Neuroglee Therapeutics

The funding injection will enable Neuroglee to launch virtual neurology clinics for patients diagnosed with mild cognitive impairment related to difficult-to-treat conditions such as Alzheimer’s disease, while also advancing the company’s DTx pipeline.